2023 Àü³²´ëÇб³º´¿ø ½ÅÀå³»°ú ¿¬¼ö°Á : 2023-09-02
±³À°ÀÏÀÚ : 2023-09-02
±³À°Àå¼Ò : Àü³²´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸Áö¿ø¼¾ÅÍ 1Ãþ ´ë°´ç
±³À°ÁÖÁ¦ : 2023 Àü³²´ëÇб³º´¿ø ½ÅÀå³»°ú ¿¬¼ö°ÁÂ
ÁÖÃÖ±â°ü : Àü³²´ëÇб³º´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÅÀå³»°ú
´ã´çÀÚ : ¼»óÇå
¿¬¶ôó : 062-220-6296
À̸ÞÀÏ : medssh19@daum.net
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ±¤ÁÖ±¤¿ª½Ã
±³À°½Ã°£ : 3 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 09¿ù 02ÀÏ ´ë°´ç 13:00~13:05 °³È¸»ç ¸¶¼º±Ç(Àü³²´ëÇб³º´¿ø ½ÅÀå³»°ú °úÀå)
±³À°½Ã°£ 09¿ù 02ÀÏ ´ë°´ç 13:05~13:35 Impact of SGLT2 inhibitors on CKD outcomes ¼»óÇå(Àü³²ÀÇ´ë)
±³À°½Ã°£ 09¿ù 02ÀÏ ´ë°´ç 13:35~14:05 RAAS blockade as a therapeutic strategy in diabetic kidney disease ¼±ÀοÀ(ÀüÁÖ¿¹¼öº´¿ø)
±³À°½Ã°£ 09¿ù 02ÀÏ ´ë°´ç 14:05~14:35 Current update of treatment for heart failure ¹ÚÇõÁø(Àü³²ÀÇ´ë)
Åä·Ð 09¿ù 02ÀÏ ´ë°´ç 14:35~14:50 Åä·Ð ÀÓ»ó¿±; ±èÇÏ¿¬; ¼Û¼öÇö; ±è¼öÀÎ(°í·ÁÀÇ´ë; ±¤ÁÖº¸Èƺ´¿ø; Àü³²ÀÇ´ë; Àü³²ÀÇ´ë)
ÈÞ½Ä 09¿ù 02ÀÏ ´ë°´ç 14:50~15:10 ÈÞ½Ä ()
±³À°½Ã°£ 09¿ù 02ÀÏ ´ë°´ç 15:10~15:40 Optimal management of osteoporosis in CKD ¿ÀÅ·Å(Àü³²ÀÇ´ë)
±³À°½Ã°£ 09¿ù 02ÀÏ ´ë°´ç 15:40~16:10 Novel therapeutics for anemia in CKD ÃÖÈ«»ó(Àü³²ÀÇ´ë)
±³À°½Ã°£ 09¿ù 02ÀÏ ´ë°´ç 16:10~16:40 Immunological perspectives of donor screening for KT ½Åº´Ã¶(Á¶¼±ÀÇ´ë)
Åä·Ð 09¿ù 02ÀÏ ´ë°´ç 16:40~16:55 Åä·Ð ¹èÀºÈñ; ÃÖÁؼ®; ±è¹Î¾Æ; Á¶´ÙÇý(Àü³²ÀÇ´ë; ´õÁ¶Àº³»°ú; Àü³²ÀÇ´ë; Àü³²ÀÇ´ë)
±âŸ 09¿ù 02ÀÏ ´ë°´ç 16:55~17:00 Æóȸ»ç ±è¼ö¿Ï(´ëÇѽÅÀåÇÐȸ È£³²Áöȸ ȸÀå)